ABOUT THE COMPANY

Biocamp. In favor of
life, naturally.

Experience, qualification, competence, development and safety. Combined to research, develop and deliver the best solutions in probiotics and vaccines for poultry production. This is what Biocamp is offering to its customers since it was founded in 1999.

The company is presently active in the national and international poultry market, and is growing as a result of its permanent search for excellence in its products, as well as investments in research and development.

The company has the structure and specialists to strictly follow the standards established in the Good Manufacturing Practices (GMP) certification, as well as the guidelines of the Ministry of Agriculture, Livestock and Food Supply (MAPA) and regulatory agencies. And also, to provide an exclusive and specialized customer service from the very beginning, the first contact, then the sale, delivery and post-sales.

Why be a Biocamp partner
Empresa | Biocamp
We have the most complete probiotics portfolio of the market and vaccines for commercial layers
We provide technical information for each business model
We offer natural solutions that meet the standards of regulatory agencies and the market requirements
customers has our full attention during the whole process
Our professional team is highly qualified and trained
Our specialized technical support is provided by veterinarians
Quality control of the production process is very strict, establishing the highest control standard and safety tests
The results of our solutions are validated by research institutes and companies that use our\ products
TIMELINE
1980
1980
1995
1995
1999
1999
2002
2002
2005
2005
2009
2009
2010
2010
2011
2011
2013
2013
2014
2014
2015
2015
2016
2016
2017
2017
2018
2018
2019
2019
2020
2020
2021
2021
2022
2022
1980 EN

CBM, A VACCINE COMPANY, WAS ESTABLISHED, THE FIRST OF THE BIOCAMP FOUNDERS.

1995 EN

CBM IS SOLD TO MALLINCKRODT (NOW CALLED MSD)

1999 EN

BIOCAMP IS BORN: REGISTRATION AND PRODUCTION OF ADDITIVES FOR ANIMAL FEEDING – PROBIOTICS FROM NORMAL AVIAN GUT FLORA (NAGF)

2002 EN

CNN, A VACCINE COMPANY, IS ESTABLISHED BY BIOCAMP FOUNDERS

2005 EN

CNN IS SOLD TO CEVA SANTÉ ANIMAL

2009 EN

THE PLANT FOR PRODUCTION OF BIOCAMP BIOLOGICALS IS BUILT

2010 EN

PROBIOTICS START TO BE EXPORTED

2011 EN

REGISTRATION FOR BIOLOGICALS PRODUCTION IS OBTAINED

2013 EN

THE CAMPVAC® SG9R LIQUID VACCINE IS LAUNCHED

PROBIOTICS COLOSTRUM® BIO 21 MIX AND COLOSTRUM® BIO 21 LIQUID ARE PRODUCED

2014 EN

RESEARCH ON LIVE AND INACTIVATED SALMONELA PARATYPHOID VACCINES IS STARTED

2015 EN

FREEZE DRIED CAMPVAC® SG9R AND FREEZE DRIED CAMPVAC® MG F ARE LAUNCHED

A NEW AREA IS ACQUIRED TO PROVIDE PHYSICAL SEPARATION BETWEEN THE MANUFACTURING AND ADMINISTRATIVE PLANTS

THE NEW STRUCTURE FOR QUALITY CONTROL OF “IN VIVO” TESTS, BIOLOGICAL ASSAYS LABORATORY (LEBB), IS INAUGURATED

2016 EN

RESEARCH ON PROBIOTICS FOR SWINE AND AQUACULTURE ARE INITIATED

2017 EN

RESEARCH ON PROBIOTICS FOR AQUACULTURE IS INCREASED

2018 EN

RESTRUCTURING OF THE PROBIOTICS PLANT WITH INVESTMENTS IN A STRUCTURE WITH LEADING EDGE TECHNOLOGY

A NEW AREA IS ACQUIRED TO EXPAND THE MANUFACTURING PLANT

2019 EN

20 YEARS

THE BIOLOGICAL PRODUCTION AREA IS EXPANDED

NEW RESEARCH & DEVELOPMENT CENTER

2020 EN

REGISTRATION OF COLOSTRUM® BIOSUIS, PROBIOTIC FOR SWINE

COMMERCIALIZATION OF AUTOVAC®, AUTOGENOUS BACTERIAL VACCINES

2021 EN

DEVELOPMENT OF NATURAL SOLUTIONS FOR AGRICULTURE

2022 EN

EXPANSION OF INTERNATIONAL OPERATIONS – ASIA AND THE MIDDLE EAST